Bio-Rad Laboratories (BIO) News Today $230.41 -0.11 (-0.05%) As of 03:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Q2 EPS Estimate for Bio-Rad Laboratories Lowered by AnalystBio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Equities researchers at Zacks Research dropped their Q2 2025 EPS estimates for Bio-Rad Laboratories in a note issued to investors on Monday, June 9th. Zacks Research analyst R. Department now forecasts that the medical research company will poJune 11 at 8:06 AM | marketbeat.comWells Fargo & Company Has Lowered Expectations for Bio-Rad Laboratories (NYSE:BIO) Stock PriceJune 11 at 2:35 AM | americanbankingnews.com1,145 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Acquired by Patriot Financial Group Insurance Agency LLCPatriot Financial Group Insurance Agency LLC acquired a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,145 shares of the medical research company's stockJune 10 at 4:29 AM | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Price Target Cut to $245.00 by Analysts at Wells Fargo & CompanyWells Fargo & Company reduced their target price on Bio-Rad Laboratories from $260.00 to $245.00 and set an "equal weight" rating on the stock in a report on Monday.June 9 at 3:30 PM | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Lowered to "Hold" Rating by Wall Street ZenJune 9 at 2:39 AM | americanbankingnews.comWellington Management Group LLP Sells 9,206 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Wellington Management Group LLP trimmed its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 91.9% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 810 shares of the medical research company's stock after selling 9,206 sharJune 8 at 3:48 AM | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Downgraded by Wall Street Zen to "Hold"Wall Street Zen cut shares of Bio-Rad Laboratories from a "buy" rating to a "hold" rating in a research report on Sunday.June 8 at 3:22 AM | marketbeat.comShort Interest in Bio-Rad Laboratories, Inc. (NYSE:BIO) Rises By 23.4%Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) was the recipient of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 1,320,000 shares, an increase of 23.4% from the April 30th total of 1,070,000 shares. Based on an average trading volume of 367,200 shares, the days-to-cover ratio is presently 3.6 days. Approximately 7.2% of the shares of the company are short sold.June 4, 2025 | marketbeat.comGAMMA Investing LLC Purchases 147,176 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)GAMMA Investing LLC raised its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 22,131.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 147,841 shares of the medical research company'sJune 4, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Hits New 12-Month Low - Here's WhyBio-Rad Laboratories (NYSE:BIO) Reaches New 52-Week Low - Time to Sell?June 3, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 10,637 shares of the medical reseJune 2, 2025 | marketbeat.comPublic Employees Retirement System of Ohio Buys New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Public Employees Retirement System of Ohio bought a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 6,731 shares of the medical research company's sJune 2, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five research firms that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and three have given a buyJune 2, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by California State Teachers Retirement SystemCalifornia State Teachers Retirement System trimmed its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 15.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 25,897 sharJune 1, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Rating Increased to Buy at Wall Street ZenJune 1, 2025 | americanbankingnews.comBio-Rad Laboratories (NYSE:BIO) Stock Rating Upgraded by Wall Street ZenWall Street Zen raised shares of Bio-Rad Laboratories from a "hold" rating to a "buy" rating in a research report on Saturday.June 1, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Holdings Lowered by Jefferies Financial Group Inc.Jefferies Financial Group Inc. reduced its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 74.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,807 shares of the medical research company's sMay 31, 2025 | marketbeat.comBio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare ConferenceMay 29, 2025 | businesswire.comSquarepoint Ops LLC Sells 8,712 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Squarepoint Ops LLC lessened its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 39.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,174 shares of the medical research company's stock after sellingMay 27, 2025 | marketbeat.comZacks Research Issues Negative Forecast for BIO EarningsBio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for Bio-Rad Laboratories in a research report issued on Thursday, May 22nd. Zacks Research analyst R. Department now anticipates that the medical research coMay 27, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $127.67 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 11.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 388,6May 26, 2025 | marketbeat.comWhat is Zacks Research's Forecast for BIO FY2027 Earnings?Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Equities researchers at Zacks Research upped their FY2027 earnings estimates for shares of Bio-Rad Laboratories in a report issued on Thursday, May 22nd. Zacks Research analyst R. Department now anticipates that the medical research company wiMay 25, 2025 | marketbeat.comWorldquant Millennium Advisors LLC Has $1.09 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Worldquant Millennium Advisors LLC trimmed its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 69.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,316 shares of the medical researcMay 25, 2025 | marketbeat.comMan Group plc Takes Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Man Group plc acquired a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 7,718 shares of the medical research company's stock, valued at approximately $2,535,000. OtherMay 25, 2025 | marketbeat.comBio-Rad’s SWOT analysis: life science firm navigates tariffs, eyes growthMay 23, 2025 | investing.comQuantinno Capital Management LP Buys 6,646 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Quantinno Capital Management LP boosted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 552.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,850 shares of the medical research company'sMay 23, 2025 | marketbeat.comBio-Rad Laboratories Q1 Earnings TranscriptMay 22, 2025 | marketbeat.comSone Capital Management LLC Buys Shares of 20,281 Bio-Rad Laboratories, Inc. (NYSE:BIO)Sone Capital Management LLC purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 20,281 shares of the medical research compMay 21, 2025 | marketbeat.comNomura Holdings Inc. Acquires New Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Nomura Holdings Inc. bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 3,055 shares of the medical research comMay 21, 2025 | marketbeat.comSelect Equity Group L.P. Has $151.33 Million Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Select Equity Group L.P. lowered its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 35.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 460,658 shares of the medical research company's stock after selMay 19, 2025 | marketbeat.comJefferies Financial Group Inc. Trims Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Jefferies Financial Group Inc. reduced its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 74.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,807 shares of the meMay 19, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) is Southeastern Asset Management Inc. TN's 8th Largest PositionSoutheastern Asset Management Inc. TN lowered its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 3.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 308,469 shares of the medical research companMay 18, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Grows Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)D. E. Shaw & Co. Inc. lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 46.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 24,625 shares of the medical research company's stock aMay 18, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Point72 Asset Management L.P.Point72 Asset Management L.P. lessened its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 1.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 247,510 shares of the medical research company's stock after selling 2,598 shares during the quarter.May 17, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Gotham Asset Management LLCGotham Asset Management LLC raised its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 21.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,949 shares of the medical research compaMay 15, 2025 | marketbeat.comCaptrust Financial Advisors Grows Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Captrust Financial Advisors grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 648.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 5,730 shares of the medical research company's stock after buying an additional 4,964 shMay 15, 2025 | marketbeat.comBio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global ...May 12, 2025 | gurufocus.comBio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare ConferenceMay 12, 2025 | businesswire.comBank of America Corp DE Has $140.37 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Bank of America Corp DE increased its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 705.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 427,292 shares of the medical research company's stocMay 12, 2025 | marketbeat.comFirst Trust Advisors LP Lowers Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)First Trust Advisors LP cut its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 94.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,093 shares of the medical research company's stock afterMay 12, 2025 | marketbeat.comBalyasny Asset Management L.P. Invests $15.46 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Balyasny Asset Management L.P. purchased a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 47,073 shares of the medical research company's stMay 11, 2025 | marketbeat.comClearline Capital LP Sells 12,244 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Clearline Capital LP decreased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 77.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,535 shares of the medical research company's stock after sellinMay 10, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Recommendation of "Moderate Buy" from AnalystsBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the five analysts that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and three have given aMay 10, 2025 | marketbeat.comBio-Rad: With Low Debt And A Stock Price Drop, Is The Company Undervalued?May 9, 2025 | seekingalpha.comCaxton Associates LP Invests $590,000 in Bio-Rad Laboratories, Inc. (NYSE:BIO)Caxton Associates LP acquired a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,797 shares of the medical research company's stock, valMay 9, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by AQR Capital Management LLCAQR Capital Management LLC lessened its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 3.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 29,380 shares of the medical research company'sMay 9, 2025 | marketbeat.comNorthern Trust Corp Increases Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Northern Trust Corp raised its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 24.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 260,868 shares of the medical research company's stock after aMay 7, 2025 | marketbeat.comBellevue Group AG Sells 12,600 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Bellevue Group AG decreased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 27.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,551 shares of the medical reMay 6, 2025 | marketbeat.comTudor Investment Corp ET AL Invests $2.44 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Tudor Investment Corp ET AL acquired a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 7,433 shares of the medical research company's stock, valued at apMay 6, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD increased its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 5.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 29,144 shares of the medicalMay 6, 2025 | marketbeat.com Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address BIO Media Mentions By Week BIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼0.581.01▲Average Medical News Sentiment BIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼117▲BIO Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Waters News Illumina News Bio-Techne News Charles River Laboratories International News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Mettler-Toledo International News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIO Stock Free BIO Stock Alerts